Learn Microsoft PowerPoint 2016 from scratch in just 14 minutes! This beginner-friendly guide helps you create professional presentations step by step with ease. #PowerPoint2016 #PresentationSkills ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

This Microsoft PowerPoint tutorial for beginners will help you to learn how to start and create it. This post will give you the step by step details and tips on how to make your presentation ...

Years of success and methodical design in Europe have Pliant well-prepared to compete in the United States. Co-founder and CEO Malte Rau believes Pliant’s genesis in a region with strict regulations ...

What if you could cut hours of tedious work into minutes, all while making sure precision and creativity? In this walkthrough, David Fortin shows how Microsoft Copilot, with its innovative generative ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. MOUNT VERNON, N.Y.—In my line of work, whether it’s eSports tournaments, televised boxing, ...

Have you ever wished your PowerPoint presentation could do more than just sit on a screen? Imagine turning your static slides into a dynamic, shareable video that captivates your audience—whether it’s ...

With Concentra Biosciences expanding its stock influence in Pliant Therapeutics and Acelyrin, the two biotechs have shored up their corporate defences against a potential acquisition. Both Pliant and ...

Pliant Therapeutics, Inc. has announced the adoption of a limited duration stockholder rights agreement aimed at protecting shareholder interests in light of recent stock accumulations. The agreement ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The two stock rights dividends ...

Pliant Therapeutics has discontinued a phase 2b/3 trial after recording at least a 7% higher rate of adverse events tied to idiopathic pulmonary fibrosis (IPF) in the treatment arms compared to ...